Related Experiment Video
Updated: Apr 18, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
A holistic approach to targeting disease with polymeric nanoparticles
Christopher J Cheng1, Gregory T Tietjen2, Jennifer K Saucier-Sawyer3
11] Department of Biomedical Engineering, Yale University, New Haven, Connecticut 06511, USA. Present address: Alexion Pharmaceuticals, Cheshire, Connecticut 06410, USA. [2].
Nanomedicine aims to enhance clinical outcomes through targeted nanoparticles. A holistic approach considering administration route, molecular traits, and timing is crucial for effective nanomedicine integration.
Area of Science:
- Nanomedicine
- Biotechnology
- Drug Delivery Systems
Background:
- Nanoparticles are engineered for targeted delivery to improve diagnostic and therapeutic efficacy.
- The concept of nanoparticle targeting has narrowed to solely increasing target affinity.
- A broader perspective is needed to fully realize nanomedicine's potential.
Purpose of the Study:
- To present a holistic view of nanoparticle targeting.
- To emphasize the simultaneous consideration of multiple design variables.
- To facilitate the clinical integration of nanomedicines.
Main Methods:
- Review and synthesis of current nanomedicine targeting strategies.
- Conceptual framework development for comprehensive nanoparticle design.
- Analysis of key design variables including administration route, molecular characteristics, and temporal control.
Main Results:
- Current targeting strategies often overlook crucial design elements.
- A holistic approach requires simultaneous optimization of administration route, molecular characteristics, and temporal control.
- Integrating these variables offers a more effective strategy for nanomedicine development.
Conclusions:
- A comprehensive vision of nanoparticle targeting is essential for advancing nanomedicine.
- Simultaneous consideration of administration, molecular properties, and timing will improve efficacy and reduce off-target effects.
- This integrated approach will accelerate the clinical application of nanomedicines.
More Related Videos
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Modified-Release Drug Delivery Systems: Site-Targeted
Pharmacogenomics: Identification of New Drug Targets

